NCT00004559

Brief Summary

To determine if the dietary N-3 class of polyunsaturated fatty acids (PUFAs) provided in the diet largely from marine fish oils would prevent fatal ventricular tachycardia (VT) or ventricular fibrillation (VF).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Mar 1999

Typical duration for phase_3

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 1999

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

February 9, 2000

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 10, 2000

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2002

Completed
Last Updated

March 16, 2016

Status Verified

November 1, 2005

First QC Date

February 9, 2000

Last Update Submit

March 15, 2016

Conditions

Interventions

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (1)

  • Leaf A, Albert CM, Josephson M, Steinhaus D, Kluger J, Kang JX, Cox B, Zhang H, Schoenfeld D; Fatty Acid Antiarrhythmia Trial Investigators. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005 Nov 1;112(18):2762-8. doi: 10.1161/CIRCULATIONAHA.105.549527.

    PMID: 16267249BACKGROUND

MeSH Terms

Conditions

Arrhythmias, CardiacHeart DiseasesTachycardia, VentricularVentricular Fibrillation

Condition Hierarchy (Ancestors)

Cardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsTachycardiaCardiac Conduction System Disease

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
PREVENTION
Sponsor Type
NIH

Study Record Dates

First Submitted

February 9, 2000

First Posted

February 10, 2000

Study Start

March 1, 1999

Study Completion

February 1, 2002

Last Updated

March 16, 2016

Record last verified: 2005-11